Michael Gould to Carcinoma, Non-Small-Cell Lung
This is a "connection" page, showing publications Michael Gould has written about Carcinoma, Non-Small-Cell Lung.
Connection Strength
5.940
-
Surveillance Imaging in Patients with Resected Non-Small Cell Lung Cancer: Too Much, Not Enough, or Just Right? Ann Am Thorac Soc. 2016 09; 13(9):1446-7.
Score: 0.535
-
Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. Chest. 2016 Apr; 149(4):943-50.
Score: 0.512
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest. 2014 Apr; 145(4):839-847.
Score: 0.452
-
The use and misuse of positron emission tomography in lung cancer evaluation. Clin Chest Med. 2011 Dec; 32(4):749-62.
Score: 0.385
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011 May; 6(5):875-83.
Score: 0.370
-
Positron emission tomography 18F-fluorodeoxyglucose uptake and prognosis in patients with surgically treated, stage I non-small cell lung cancer: a systematic review. J Thorac Oncol. 2009 Dec; 4(12):1473-9.
Score: 0.335
-
Timeliness across the continuum of care in veterans with lung cancer. J Thorac Oncol. 2008 Sep; 3(9):951-7.
Score: 0.307
-
Variation in experts' beliefs about lung cancer growth, progression, and prognosis. J Thorac Oncol. 2008 Apr; 3(4):422-6.
Score: 0.298
-
Timeliness of care in veterans with non-small cell lung cancer. Chest. 2008 May; 133(5):1167-73.
Score: 0.296
-
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006 Nov; 1(9):953-9.
Score: 0.271
-
When in doubt should we cut it out? The role of surgery in non-small cell lung cancer. Thorax. 2006 Jul; 61(7):554-6.
Score: 0.264
-
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005 Nov; 60(11):949-55.
Score: 0.247
-
Multidisciplinary management of lung cancer. N Engl J Med. 2004 May 06; 350(19):2008-10; author reply 2008-10.
Score: 0.228
-
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92.
Score: 0.221
-
The benefits and harms of adjuvant chemotherapy for non-small cell lung cancer in patients with major comorbidities: A simulation study. PLoS One. 2022; 17(11):e0263911.
Score: 0.206
-
Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
Score: 0.172
-
Knowledge Gaps and Research Priorities in Immune Checkpoint Inhibitor-related Pneumonitis. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2019 09 15; 200(6):e31-e43.
Score: 0.165
-
Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558.
Score: 0.141
-
Radiotherapy for brain metastases near the end of life in an integrated health care system. Ann Palliat Med. 2017 Aug; 6(Suppl 1):S28-S38.
Score: 0.140
-
Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May; 143(5 Suppl):e211S-e250S.
Score: 0.106
-
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer. 2011 Jun 07; 11:228.
Score: 0.093
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.084
-
Noninvasive staging of non-small cell lung cancer: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest. 2007 Sep; 132(3 Suppl):178S-201S.
Score: 0.072
-
Usefulness of positron emission tomography imaging in the management of lung cancer. Curr Opin Pulm Med. 1999 Jul; 5(4):201-7.
Score: 0.041